| scholarly article | Q13442814 |
| P50 | author | Toby Maher | Q42886895 |
| P2093 | author name string | Huzaifa I Adamali | |
| P2860 | cites work | Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation | Q47650348 |
| High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis | Q47661325 | ||
| A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis | Q48033849 | ||
| TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? | Q74219134 | ||
| The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma | Q74595761 | ||
| Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy | Q74769093 | ||
| Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study | Q77293047 | ||
| Reduction of endothelial cell related TGFbeta activity by thiols | Q77871907 | ||
| Experimental aspiration pneumonia. IV. Inflammatory and reparative changes produced by intratracheal injections of autologous gastric juice and hydrochloric acid | Q78752679 | ||
| Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias | Q79667658 | ||
| Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis | Q79714924 | ||
| Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation | Q81398566 | ||
| Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease | Q85110868 | ||
| Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. | Q50756212 | ||
| Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. | Q50853560 | ||
| International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. | Q53253288 | ||
| Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. | Q53578148 | ||
| Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. | Q54346034 | ||
| Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice | Q57217570 | ||
| The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin | Q57966311 | ||
| TISSUE INHIBITOR OF METALLOPROTEINASE-3 IS UP-REGULATED BY TRANSFORMING GROWTH FACTOR-β1 IN VITRO AND EXPRESSED IN FIBROBLASTIC FOCI IN VIVO IN IDIOPATHIC PULMONARY FIBROSIS | Q58211728 | ||
| The expanding world of small RNAs | Q59054825 | ||
| Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis | Q69941053 | ||
| The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis | Q72020291 | ||
| Pulmonary effects of experimental graded aspiration of hydrochloric acid | Q72399203 | ||
| Inhibition of myofibroblast apoptosis by transforming growth factor beta(1) | Q73205575 | ||
| Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis | Q73734162 | ||
| Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression | Q73977470 | ||
| A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis | Q21135329 | ||
| Non-steroid agents for idiopathic pulmonary fibrosis | Q24235478 | ||
| Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence | Q24310163 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 | ||
| Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK | Q24670477 | ||
| Growth factors in idiopathic pulmonary fibrosis: relative roles | Q24798972 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans | Q27860895 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| Making sense of latent TGFbeta activation | Q28217641 | ||
| The rising incidence of idiopathic pulmonary fibrosis in the U.K | Q28236424 | ||
| Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials | Q28237583 | ||
| A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis | Q28266119 | ||
| Pirfenidone in idiopathic pulmonary fibrosis | Q28267108 | ||
| High-dose acetylcysteine in idiopathic pulmonary fibrosis | Q28283438 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis | Q28308276 | ||
| Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung | Q30311027 | ||
| Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. | Q33605234 | ||
| Non-coding RNAs: a key to future personalized molecular therapy? | Q33762263 | ||
| Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. | Q33855774 | ||
| Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis | Q33994636 | ||
| Pirfenidone in idiopathic pulmonary fibrosis. | Q37777648 | ||
| MicroRNAs in idiopathic pulmonary fibrosis. | Q37855082 | ||
| Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment | Q37915893 | ||
| Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. | Q37988113 | ||
| Cross-linking amino acids in collagen and elastin | Q38810706 | ||
| Latent herpesvirus infection augments experimental pulmonary fibrosis | Q39342306 | ||
| Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment | Q39659310 | ||
| The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells. | Q39669856 | ||
| Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression. | Q39962123 | ||
| Lysine hydroxylation and cross-linking of collagen | Q39997478 | ||
| The diagnosis of idiopathic pulmonary fibrosis and its complications | Q40024041 | ||
| Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. | Q40216430 | ||
| A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis | Q40631272 | ||
| Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
| Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine | Q41020995 | ||
| Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung | Q41068693 | ||
| Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis | Q41690993 | ||
| Aspiration of gastric contents; an experimental study. | Q42428511 | ||
| Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. | Q42819775 | ||
| Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results | Q43223134 | ||
| Protection from pulmonary fibrosis in the absence of CCR2 signaling | Q43760123 | ||
| Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis | Q44160763 | ||
| Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association? | Q44307938 | ||
| The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis | Q44413322 | ||
| CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis | Q44650088 | ||
| The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report--2011. | Q44757809 | ||
| Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice | Q45285621 | ||
| Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis | Q45394865 | ||
| Induction of transforming growth factor-beta 1 production in human cells by herpes simplex virus | Q45743191 | ||
| The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis | Q45750246 | ||
| Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays | Q46553815 | ||
| Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterization | Q46581036 | ||
| Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. | Q46680589 | ||
| Anticoagulant therapy for idiopathic pulmonary fibrosis | Q46703272 | ||
| TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis | Q46740234 | ||
| Antioxidant therapy for idiopathic pulmonary fibrosis | Q46818803 | ||
| Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-beta1 production and fibroblast proliferation | Q46972320 | ||
| ??? | Q28215495 | ||
| miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis | Q34044475 | ||
| Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo | Q34187677 | ||
| Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis | Q34223462 | ||
| Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis | Q34275871 | ||
| CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury | Q34399563 | ||
| LMP1 structure and signal transduction | Q34415978 | ||
| Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. | Q34434384 | ||
| Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis | Q34554406 | ||
| Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types | Q34598816 | ||
| Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis | Q34791876 | ||
| The myofibroblast in pulmonary fibrosis | Q35022198 | ||
| Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis | Q35027515 | ||
| Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study | Q35028793 | ||
| Molecular mechanisms of N-acetylcysteine actions | Q35076338 | ||
| Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis | Q35087744 | ||
| miR-29 is a major regulator of genes associated with pulmonary fibrosis. | Q35219800 | ||
| Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis | Q35533486 | ||
| The role of transforming growth factor beta in lung development and disease | Q35652666 | ||
| Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis | Q35683001 | ||
| Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice | Q35855163 | ||
| Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis | Q36103471 | ||
| Acute exacerbations of idiopathic pulmonary fibrosis | Q36168860 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis | Q36330655 | ||
| Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta | Q36352371 | ||
| Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series | Q36421434 | ||
| Current perspectives on the treatment of idiopathic pulmonary fibrosis | Q36493955 | ||
| Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. | Q36907900 | ||
| Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia | Q37120665 | ||
| Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis | Q37558464 | ||
| MicroRNAs in common diseases and potential therapeutic applications | Q37577960 | ||
| Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis | Q37591872 | ||
| Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome | Q37769355 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 261-272 | |
| P577 | publication date | 2012-09-26 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | Current and novel drug therapies for idiopathic pulmonary fibrosis | |
| P478 | volume | 6 |
| Q52657953 | A novel computational approach for drug repurposing using systems biology. |
| Q36438280 | A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair |
| Q53828437 | Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells. |
| Q37421028 | Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway |
| Q41812311 | Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling. |
| Q38288028 | Diagnosis and management of interstitial lung disease |
| Q38168037 | Host-directed therapeutics for tuberculosis: can we harness the host? |
| Q92246784 | Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice |
| Q52659029 | Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation. |
| Q35558781 | Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis |
| Q38130161 | New approaches to modulating idiopathic pulmonary fibrosis |
| Q33856238 | Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis |
| Q26852032 | Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps |
| Q33718504 | Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C. |
| Q46113966 | TGF-β1 Signaling and Tissue Fibrosis |
| Q37730259 | Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/ angiotensin-(1-7) axis in rats |
| Q38181073 | The epithelium in idiopathic pulmonary fibrosis: breaking the barrier |
| Q37621515 | The treatment of idiopathic pulmonary fibrosis. |
| Q35992491 | Total Glucosides of Danggui Buxue Tang Attenuate BLM-Induced Pulmonary Fibrosis via Regulating Oxidative Stress by Inhibiting NOX4. |
Search more.